Cargando…

Public opinion of a stroke clinical trial using exception from informed consent

BACKGROUND: Acute stroke is a leading cause of morbidity and mortality. Clinical trials in stroke are challenging because victims often do not have the capacity to provide informed consent, excluding those patients most likely to benefit from the research. AIM: We evaluated patient willingness to pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Goldstein, Joshua N., Espinola, Janice A., Fisher, Jonathan, Pallin, Daniel J., Camargo, Carlos A.
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3047845/
https://www.ncbi.nlm.nih.gov/pubmed/21373310
http://dx.doi.org/10.1007/s12245-010-0244-2
_version_ 1782199081670541312
author Goldstein, Joshua N.
Espinola, Janice A.
Fisher, Jonathan
Pallin, Daniel J.
Camargo, Carlos A.
author_facet Goldstein, Joshua N.
Espinola, Janice A.
Fisher, Jonathan
Pallin, Daniel J.
Camargo, Carlos A.
author_sort Goldstein, Joshua N.
collection PubMed
description BACKGROUND: Acute stroke is a leading cause of morbidity and mortality. Clinical trials in stroke are challenging because victims often do not have the capacity to provide informed consent, excluding those patients most likely to benefit from the research. AIM: We evaluated patient willingness to participate in a hypothetical acute stroke trial using an exception from informed consent. METHODS: Consecutive patients presenting to four emergency departments (EDs) underwent structured interviews regarding a hypothetical stroke trial using an exception from informed consent. RESULTS: Of 461 (72% of eligible) participants, 55% (95% CI, 50%–59%) were willing to be enrolled in the hypothetical study without giving informed consent. After multivariable analysis, independent predictors of willingness to enroll included Catholic religion (OR 1.57, 95% CI 1.17–2.10) and belief that current therapy offers a >50% chance of full recovery (OR 1.29, 95% CI 1.05–1.57). There was no difference between the proportion willing to enroll in a cardiac arrest study vs. a stroke study (55% vs. 55%, p = 0.83) CONCLUSIONS: Fifty-five percent of ED patients would be willing to be enrolled in a stroke trial using exception from informed consent.
format Text
id pubmed-3047845
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Springer-Verlag
record_format MEDLINE/PubMed
spelling pubmed-30478452011-03-03 Public opinion of a stroke clinical trial using exception from informed consent Goldstein, Joshua N. Espinola, Janice A. Fisher, Jonathan Pallin, Daniel J. Camargo, Carlos A. Int J Emerg Med Brief Research Report BACKGROUND: Acute stroke is a leading cause of morbidity and mortality. Clinical trials in stroke are challenging because victims often do not have the capacity to provide informed consent, excluding those patients most likely to benefit from the research. AIM: We evaluated patient willingness to participate in a hypothetical acute stroke trial using an exception from informed consent. METHODS: Consecutive patients presenting to four emergency departments (EDs) underwent structured interviews regarding a hypothetical stroke trial using an exception from informed consent. RESULTS: Of 461 (72% of eligible) participants, 55% (95% CI, 50%–59%) were willing to be enrolled in the hypothetical study without giving informed consent. After multivariable analysis, independent predictors of willingness to enroll included Catholic religion (OR 1.57, 95% CI 1.17–2.10) and belief that current therapy offers a >50% chance of full recovery (OR 1.29, 95% CI 1.05–1.57). There was no difference between the proportion willing to enroll in a cardiac arrest study vs. a stroke study (55% vs. 55%, p = 0.83) CONCLUSIONS: Fifty-five percent of ED patients would be willing to be enrolled in a stroke trial using exception from informed consent. Springer-Verlag 2010-11-10 /pmc/articles/PMC3047845/ /pubmed/21373310 http://dx.doi.org/10.1007/s12245-010-0244-2 Text en © © The Author(s). This article is published with open access at Springerlink.com 2010 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Brief Research Report
Goldstein, Joshua N.
Espinola, Janice A.
Fisher, Jonathan
Pallin, Daniel J.
Camargo, Carlos A.
Public opinion of a stroke clinical trial using exception from informed consent
title Public opinion of a stroke clinical trial using exception from informed consent
title_full Public opinion of a stroke clinical trial using exception from informed consent
title_fullStr Public opinion of a stroke clinical trial using exception from informed consent
title_full_unstemmed Public opinion of a stroke clinical trial using exception from informed consent
title_short Public opinion of a stroke clinical trial using exception from informed consent
title_sort public opinion of a stroke clinical trial using exception from informed consent
topic Brief Research Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3047845/
https://www.ncbi.nlm.nih.gov/pubmed/21373310
http://dx.doi.org/10.1007/s12245-010-0244-2
work_keys_str_mv AT goldsteinjoshuan publicopinionofastrokeclinicaltrialusingexceptionfrominformedconsent
AT espinolajanicea publicopinionofastrokeclinicaltrialusingexceptionfrominformedconsent
AT fisherjonathan publicopinionofastrokeclinicaltrialusingexceptionfrominformedconsent
AT pallindanielj publicopinionofastrokeclinicaltrialusingexceptionfrominformedconsent
AT camargocarlosa publicopinionofastrokeclinicaltrialusingexceptionfrominformedconsent